News and Comments

YES AMGEN IS THE KING

  Wednesday, December 18, 2013

When Amgen (AMGN) develops a drug, the wise King does whatever it takes to squeeze every drop of its therapeutic capability before submitting the new drug application (NDA) to the FDA for approval. The firm is rich in its science, scientists, pipeline of investigational products and its approved products. All the problems the firm encountered that analysts believed would erode its fortune, such as limiting the use of its growth factors did not impact the firm’s growth, but unveiled the character and culture that made the king deserve its throne.   More...

GILEAD SCIENCES: A UNIQUE STALLION

  Monday, December 09, 2013

Taking down Gilead (GILD) seems to be beyond the reach authors of tales intended to frighten investors into selling this outstanding stock. The attempts have been repetitive but short of success. Gilead is a stallion. Unlike stallions, the horses whose muscular superiority over other horses is genetically derived, Gilead’s power is acquired through a unique culture that embraces the power of intuition, self-confidence, common sense and courage. Using an optimal amount of faith, the firm turned intuition into inspiration and using courage and wisdom, the Stallion carried out inspired tasks fated unattainable by others.  More...


Recent Postings


Archive


Tags

CompuGen (CGEN) Micromet (MITI) Agenus (AGEN Prosensa (RNA) Array Pharmaceuticals (ARRY) Intercept (ICPT) Pluristem (PSTI) Epizyme (EPZM) Xoma (XOMA) Spike Therapeutics (ONCE) HALOZYME (HALO) Human Genome Sciences (HGSI) Adaptimmune (ADAP) Tysabri Herceptin Anadys (ANDS) Valeant Pharmaceuticals International (VRX) Alder Biopharmaceuticals (ALDR) Jazz Pharmaceuticals (JAZZ) MODERNA Trastuzumab-DM1 Bellicum (BLCM) Onyx (ONXX) PTC Therapeutics (PTCT) Cytokinetics (CYTK) CEMPRA (CEMP) NEKTAR (NKTR)) Velcade (bortezomib) RenenxBio (RGNX) Illumina (ILMN) ACADIA (ACAD) AERIE PHARMACEUTICALS KITE (KITE) Global Cell Therapeutics (GBT) NANTKWEST (NK) Ridaforolimus Auspex (ASPX) AstraZeneca (AZN) galapagos (GLPG) SUNESIS PHARMACEUTICALS (SNSS) Inovio (INO) Endometrial Cancer Anacor (ANAC) NOVOCURE (NVCR) Incyte (INCY) Biogen Idec (BIIB) PORTOLA (PTLA) JUNO (JUNO) ImmunoGen (IMGN) Revlimid (lenolidamide) Alnylam (ALNY) Exelixis (EXEL) BIOMARIN (BMRN) SYNTA (SNTA) Multiple Myeloma ABBVIE (ABBV) Abbott Laboratories (ABT) Gilead (GILD) Akebia Therapeutics (AKAB) Sanofi-Aventis (SAN) Vertex (VRTX) Ionis (IONS) VANDA (VNDA) Idenix (IDIX) GUARDIAN HEALTH KERYX (KERX) ZALTRAP™ Agenus (AGEN) Bristol-Myers Squibb (BMY) Mirati Therapeutics (MRTX) JOUNCE THERAPEUTICS (JNCE) Benlysta (belimumab) Editas (EDIT) IDERA (IDRA) Ziofpharm (ZIOP) Regeneron (REGN) REGULUS (RGLS) Genentech Intrexon (XON) Elan (ELN) OncoCyte (OCX) Galena (GALE) Theravance (THRX) OSI (OSIP) ARGOS (ARGS) Sarepta (SRPT) Advaxis (ADXS) ARCA (ABIO) SERES THERAPEUTICS (MCRB) Human Longevity (HLI) Amgen (AMGN) ADVENTRIX (ANX) LEXICON (LXRX) AGOS (ARGS) CRISPR Therapeutics (CRSP) INNOVIVA (INVA) Biocryst (BCRX) Ocular Therapeutix (OCUL) Telaprevir Rapamune Sanofi (SNA) TOKAI (TKAOI) Sanofi (SNY) Sangamo (SGMO) GlaxoSmithKline (GSK) Dendreon (DNDN) Roche (ROCHE) Seattle Genetics (SGEN) ISIS (ISIS) C4 Therapeutics Prolor Biotech (PBTH) Vitae Pharmaceuticals (VTAE) GlycoMimetics (GLYN) Dynavax (DVAX) Theravance Bio Pharma (TBPH) Merck (MRK) Roche (RHHBY) Ariad (ARIA) NEUROCRINE (NBIX) Zerenex Aimmune Therapeutics (AIMT) Sequenom (SQNM) Intermune (ITMN)